OmniVis: Difference between revisions
Content deleted Content added
Blogs are not reliable sources |
added citation, removed "key people" part and removed headings, made it more narrative. some copy edits |
||
| Line 6: | Line 6: | ||
---- |
---- |
||
'''OmniVis''' is a US-based company that specialises in rapid medical diagnostic tests.<ref name=":0">{{Cite news|last=Joe Palca and Susie Neilson|date=7 Aug 2019|title=This Handy New Device Might Help KO Cholera|language=en|work=NPR.org|url=https://www.npr.org/sections/goatsandsoda/2019/08/07/749100484/this-handy-new-device-might-help-kayo-cholera|access-date=2021-10-31}}</ref><ref>{{Cite web|date=2019-02-15|title=Purdue Spinout OmniVis Commercializing Smartphone-Based Cholera Test|url=https://www.genomeweb.com/pcr/purdue-spinout-omnivis-commercializing-smartphone-based-cholera-test|access-date=2021-11-02|website=Genomeweb|language=en}}</ref> |
'''OmniVis''' is a US-based technology company that specialises in rapid [[Medical diagnosis|medical diagnostic]] tests.<ref name=":0">{{Cite news|last=Joe Palca and Susie Neilson|date=7 Aug 2019|title=This Handy New Device Might Help KO Cholera|language=en|work=NPR.org|url=https://www.npr.org/sections/goatsandsoda/2019/08/07/749100484/this-handy-new-device-might-help-kayo-cholera|access-date=2021-10-31}}</ref><ref>{{Cite web|date=2019-02-15|title=Purdue Spinout OmniVis Commercializing Smartphone-Based Cholera Test|url=https://www.genomeweb.com/pcr/purdue-spinout-omnivis-commercializing-smartphone-based-cholera-test|access-date=2021-11-02|website=Genomeweb|language=en}}</ref><ref>Prashantham, Shameen. Gorillas Can Dance: Lessons from Microsoft and Other Corporations on Partnering with Startups. United Kingdom: Wiley, 2021. p.p. lviii</ref> |
||
{{Company |
{{Company |
||
| Line 14: | Line 14: | ||
| key_people = Katherine Clayton, CEO |
| key_people = Katherine Clayton, CEO |
||
| website = www.omnivistech.com |
| website = www.omnivistech.com |
||
| ⚫ | }}OmiVis's ''OmniTech'' rapid [[Cholera]] detection device can identify the presence of ''[[Vibrio cholerae]]'' in water in approximately 30 minutes.<ref name=":0" /> ''OmniTech'' uses a process of [[Gene amplification|DNA amplification]] and [[viscosity]] measurement and costs approximately US$10 per test.<ref name=":2">{{Cite web|last=Coldewey|first=Devin|date=2 Oct 2019|title=OmniVis could save lives by detecting cholera-infected water in minutes rather than days|url=https://social.techcrunch.com/2019/10/02/omnivis-could-save-lives-by-detecting-cholera-infected-water-in-minutes-rather-than-days/|url-status=live|access-date=2021-10-31|website=TechCrunch|language=en-US}}</ref> |
||
}} |
|||
The processing is done on an [[Android (operating system)|Android]] [[smartphone]]<ref name=":2" /> that analyses water samples that are put into a single use test kit element.<ref name=":0" /> |
|||
== Diagnostic tests == |
|||
=== Cholera === |
|||
| ⚫ | OmniTech rapid [[Cholera]] detection device can identify the presence of ''[[Vibrio cholerae]]'' in water in approximately 30 minutes.<ref name=":0" /> OmniTech uses a process of [[Gene amplification|DNA amplification]] and [[viscosity]] measurement<ref name=":2">{{Cite web|last=Coldewey|first=Devin|date=2 Oct 2019|title=OmniVis could save lives by detecting cholera-infected water in minutes rather than days|url=https://social.techcrunch.com/2019/10/02/omnivis-could-save-lives-by-detecting-cholera-infected-water-in-minutes-rather-than-days/|url-status=live|access-date=2021-10-31|website=TechCrunch|language=en-US}}</ref> |
||
The current design is not well suited for large scale testing due to the small volume that can be tested.<ref name=":0" /> |
The current design is not well suited for large scale testing due to the small volume that can be tested.<ref name=":0" /> |
||
=== COVID-19 === |
|||
In May 2020 OmniVis was working on the early stages of a [[Rapid diagnostic test|rapid test]] for [[COVID-19]]<ref name=":3">{{Cite news|last=Marcus|first=Brianna Abbott and Amy Dockser|date=2020-05-26|title=Race Is On to Create Rapid Covid-19 Tests for the Fall|language=en-US|work=Wall Street Journal|url=https://www.wsj.com/articles/race-is-on-to-create-rapid-covid-19-tests-for-the-fall-11590494400|access-date=2021-10-31|issn=0099-9660}}</ref> that detects the disease in human saliva. The rapid tests uses a smartphone for processing.<ref name=":3" /> |
In May 2020 OmniVis was working on the early stages of a [[Rapid diagnostic test|rapid test]] for [[COVID-19]]<ref name=":3">{{Cite news|last=Marcus|first=Brianna Abbott and Amy Dockser|date=2020-05-26|title=Race Is On to Create Rapid Covid-19 Tests for the Fall|language=en-US|work=Wall Street Journal|url=https://www.wsj.com/articles/race-is-on-to-create-rapid-covid-19-tests-for-the-fall-11590494400|access-date=2021-10-31|issn=0099-9660}}</ref> that detects the disease in human saliva. The rapid tests uses a smartphone for processing.<ref name=":3" /> |
||
== Key people == |
|||
Katherine Clayton PhD, Founder & CEO.<ref name=":0" /> |
|||
== References == |
== References == |
||
Revision as of 19:29, 17 December 2021
 | This article, OmniVis, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |
| This article, OmniVis, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |
Comment: Remove all non-notable awards to start with. Nomadicghumakkad (talk) 20:44, 1 November 2021 (UTC)
OmniVis is a US-based technology company that specialises in rapid medical diagnostic tests.[1][2][3]
| Founded | 2017 |
|---|---|
| Headquarters | San Francisco, California, USA |
Key people | Katherine Clayton, CEO |
| Website | www.omnivistech.com |
OmiVis's OmniTech rapid Cholera detection device can identify the presence of Vibrio cholerae in water in approximately 30 minutes.[1] OmniTech uses a process of DNA amplification and viscosity measurement and costs approximately US$10 per test.[4]
The processing is done on an Android smartphone[4] that analyses water samples that are put into a single use test kit element.[1]
The current design is not well suited for large scale testing due to the small volume that can be tested.[1]
In May 2020 OmniVis was working on the early stages of a rapid test for COVID-19[5] that detects the disease in human saliva. The rapid tests uses a smartphone for processing.[5]
References
- ^ a b c d Joe Palca and Susie Neilson (7 Aug 2019). "This Handy New Device Might Help KO Cholera". NPR.org. Retrieved 2021-10-31.
- ^ "Purdue Spinout OmniVis Commercializing Smartphone-Based Cholera Test". Genomeweb. 2019-02-15. Retrieved 2021-11-02.
- ^ Prashantham, Shameen. Gorillas Can Dance: Lessons from Microsoft and Other Corporations on Partnering with Startups. United Kingdom: Wiley, 2021. p.p. lviii
- ^ a b Coldewey, Devin (2 Oct 2019). "OmniVis could save lives by detecting cholera-infected water in minutes rather than days". TechCrunch. Retrieved 2021-10-31.
{{cite web}}: CS1 maint: url-status (link) - ^ a b Marcus, Brianna Abbott and Amy Dockser (2020-05-26). "Race Is On to Create Rapid Covid-19 Tests for the Fall". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-10-31.